Clinical Trial Update: Methylphenidate in Treating Patients With Fatigue Caused by Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating methylphenidate for cancer-related fatigue in adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Fatigue

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Fatigue, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | Status: COMPLETED | Results posted: 2014-10-10